Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9050344 Therapeutic compounds

Patent 9050344 was granted and assigned to Gilead Sciences on June, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gediminas Brizgys0

Chien-Hung Chou0

Jennifer R. Zhang0

John R. Somoza0

Qi Liu0

Randall L. Halcomb0

Winston C. Tse0

Yunfeng Eric Hu0

Date of Patent

June 9, 2015

0

Patent Application Number

141517580

Date Filed

January 9, 2014

0

Patent Citations Received

US Patent 11944611 Capsid inhibitors for the treatment of HIV

0

US Patent 11993583 Therapeutic compounds

0

US Patent 12084467 Therapeutic compounds for HIV virus infection

0

US Patent 11685728 Capsid inhibitors for the prevention of HIV

0

US Patent 11680064 Capsid inhibitors for the treatment of HIV

0

US Patent 11753399 Therapeutic compounds

US Patent 11760746 Methods and intermediates for preparing therapeutic compounds

US Patent 11833143 Choline salt forms of an HIV capsid inhibitor

0

...

Patent Primary Examiner

Taofiq A. Solola

0

Patent abstract

Compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9050344 Therapeutic compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool